Bharat Biotech has begun chikungunya vaccine Phase I trial
The Hyderabad-based Bharat Biotech has begun a Phase I human clinical trial of the indigenously developed chikungunya vaccine three months ago. The vaccine uses a killed virus. The Phase I…
Category: Clinical trial
Seventy-year journey of Zika virus
Zika is an arbovirus infection which occurs through the bite of several different species of Aedes mosquitoes, including the Aedes aegypti which is active during the day; it can also…
The big test for malaria vaccine RTS,S
Beginning next year, the World Health Organisation will begin pilot tests of the injectable malaria vaccine RTS,S (or Mosquirix) on 750,000 children aged 5-17 months in Ghana, Kenya and Malawi.…
Zika vaccine Phase I trial to begin next month in India
Bharat Biotech International Ltd in Hyderabad will start a Phase I clinical trial of Zika virus vaccine (MR 766) in two centres in India next month. The inactivated vaccine being…
Bharat Biotech’s Zika virus vaccine confers 100% protection in mice
The Hyderabad-based Bharat Biotech’s killed (inactivated) Zika virus vaccine using an African strain (MR 766) has shown 100% efficacy against mortality and disease in animal studies. A ‘killed virus vaccine’…
TB vaccine trial on adults begins in June in India
In June this year, the Pune-based Serum Institute of India Pvt Limited will begin a Phase II/III vaccine trial for tuberculosis using a novel, recombinant BCG (bacillus Calmette-Guérin) vaccine. The…
India begins caged trials of GM mosquitoes to control dengue, chikungunya
Outdoor caged trials to demonstrate the efficiency of genetically modified mosquitoes to suppress wild female Aedes aegypti mosquito populations that causes dengue, chinkungunya and Zika were launched on January 23…
Indian researchers enhance BCG vaccine efficacy using anti-leprosy drug
Indian researchers have been able to bring about more than 50-fold improvement in the efficacy of the commonly used TB vaccine — Bacillu Calmette Guerin (BCG) — by giving mice…
